We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Evaluating the Safety and the Biological Effects of Intratumoral Interferon Gamma and a Peptide-Based Vaccine in Patients With Melanoma (Mel 51)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00977145
Recruitment Status : Terminated (Closed short of the enrollment goal, due to slow enrollment and adequate data to address endpoints)
First Posted : September 15, 2009
Last Update Posted : December 16, 2016
Information provided by (Responsible Party):
Craig L Slingluff, Jr, University of Virginia

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Primary Completion Date : October 2012
  Study Completion Date : No date given